Module 8: Pathophysiology of ALS
ALS Education - ALS Academy Supported by MTPAIn this module, Terry Heiman-Patterson, MD discusses the pathophysiology of ALS, and considers how disease models may lead to improved therapeutics that are designed to address the pathologic mechanisms involved in ALS. This content is supported by Mitsubishi Tanabe Pharma America (MTPA). MTPA employees do not have access to the MedShr platform. Please email info@medshr.net if you would like further information.
This module contains multiple choice questions.